- Home
- MCRB vs IH Comparison
MCRB vs IH Comparison
Compare MCRB & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- IH
- Stock Information
- Founded
- MCRB 2010
- IH 1996
- Country
- MCRB United States
- IH China
- Employees
- MCRB N/A
- IH N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- IH Other Consumer Services
- Sector
- MCRB Health Care
- IH Real Estate
- Exchange
- MCRB Nasdaq
- IH Nasdaq
- Market Cap
- MCRB 125.7M
- IH 146.3M
- IPO Year
- MCRB 2015
- IH 2020
- Fundamental
- Price
- MCRB $19.44
- IH $2.82
- Analyst Decision
- MCRB Hold
- IH
- Analyst Count
- MCRB 4
- IH 0
- Target Price
- MCRB $73.67
- IH N/A
- AVG Volume (30 Days)
- MCRB 126.4K
- IH 24.1K
- Earning Date
- MCRB 08-06-2025
- IH 09-26-2025
- Dividend Yield
- MCRB N/A
- IH 3.04%
- EPS Growth
- MCRB N/A
- IH N/A
- EPS
- MCRB 10.22
- IH 0.26
- Revenue
- MCRB N/A
- IH $123,701,096.00
- Revenue This Year
- MCRB N/A
- IH $39.02
- Revenue Next Year
- MCRB N/A
- IH N/A
- P/E Ratio
- MCRB $1.98
- IH $10.69
- Revenue Growth
- MCRB N/A
- IH N/A
- 52 Week Low
- MCRB $6.53
- IH $1.47
- 52 Week High
- MCRB $26.40
- IH $3.60
- Technical
- Relative Strength Index (RSI)
- MCRB 69.44
- IH 53.07
- Support Level
- MCRB $15.79
- IH $2.57
- Resistance Level
- MCRB $18.12
- IH $2.84
- Average True Range (ATR)
- MCRB 1.51
- IH 0.17
- MACD
- MCRB 0.28
- IH -0.02
- Stochastic Oscillator
- MCRB 97.69
- IH 68.09
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.